News
Bionow | News
· ... expertise in the promising field of cell-based therapies,” commented Juergen Weisser, Chief Executive Officer, RheinCell The…utics.
Catalent to Acquire RheinCell The…utics - Catalent Cell & Gene...
The deal will enable Catalent to offer the building blocks to scale iPSC-based cell therapies while reducing barriers to entry to the clinic.
Catalent To Acquire RheinCell The…utics | Contract Pharma
Strengthens path towards industrialization of induced pluripotent stem cell-based therapies.
sortiert nach Relevanz / Datum